HIV-associated malignancies in children.

Area of Science:

• Pediatric Oncology
• Infectious Diseases
• Epidemiology

Background:

• HIV-infected children have a significantly increased risk of developing various cancers.
• Cancers in this population are often associated with immunosuppression and oncogenic coinfections.
• Sub-Saharan Africa has the highest burden of HIV-infected children, yet cancer data remains limited.

Purpose of the Study:

• To review the current literature on the epidemiology of cancer in HIV-infected children.
• To explore the prevention strategies for cancer in this vulnerable population.
• To highlight the need for better data from high-burden regions.

Main Methods:

• Literature review of existing studies on pediatric HIV and cancer.
• Analysis of factors influencing cancer risk, including age at cART initiation and immunosuppression levels.
• Examination of the role of vaccination in cancer prevention.

Main Results:

• Combined antiretroviral therapy (cART) reduces cancer risk, but risk remains elevated if initiated later or with advanced immunosuppression.
• Early initiation of cART before severe immunosuppression is crucial for cancer prevention.
• Human papillomavirus (HPV) vaccination may offer protection against HPV-associated cancers, but optimal strategies for HIV-infected children require further research.

Conclusions:

• Effective cancer prevention in HIV-infected children hinges on timely cART initiation and potentially HPV vaccination.
• Urgent need for comprehensive data on cancer risks and prevention effectiveness in high HIV prevalence areas.
• Further research is essential to optimize vaccination strategies for HIV-infected children and young women.